Spot Trading’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Spot Trading’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$73K	Sell	25,199 -1,082	-4%	-$3.69K	﹤0.01%	2649
2017 Q2	$117K	Buy	26,281 +7,982	+44%	+$32.9K	﹤0.01%	2518
2017 Q1	$85K	Buy	+18,299	New	+$106K	﹤0.01%	2321
2016 Q2	–	Sell	-28,187	Closed	-$95.5K	–	4051
2016 Q1	$78K	Buy	+28,187	New	+$102K	﹤0.01%	2661
2014 Q4	–	Sell	-27,454	Closed	-$76K	–	4591
2014 Q3	$76K	Sell	27,454 -6,315	-19%	-$22.9K	﹤0.01%	3629
2014 Q2	$137K	Buy	+33,769	New	+$143K	﹤0.01%	3558

Other funds holding SGYP

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Spot Trading's SGYP Position: Q3 2017 in Review

Spot Trading reduced its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 4.1% in Q3 2017, selling an estimated $3.69K and leaving 25,199 shares worth $73K. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Spot Trading first reported a position in SGYP in Q2 2014 and has held it in 6 quarters since. The position peaked at $137K in Q2 2014. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

Spot Trading held 25,199 shares of Synergy Pharmaceuticals, Inc Common Stock worth $73K as of Q3 2017.
Spot Trading sold 1,082 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $3.69K.
Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2649 holding.
Spot Trading first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and has held it in 6 quarters since.
Spot Trading's Synergy Pharmaceuticals, Inc Common Stock position peaked at $137K in Q2 2014.
143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.